I am just out of the Amarin AGM- 2013. This is probably the hottest day this year. Shelbourne- 9th July.
10 staff members and one independent in the room. All motions passed. David stack voted onto Board.
A small presentation shown for the independent observer. Not much new, Jelis , Comparison of Vascepa vs lovaza, progress to date.
The current scripts have been updated. Slides to appear soon on website. There will be two new slides. YOY comparison of goals, e.g. patents July 2012, 1, patents July 2013 ,25.
Other slide is the scripts updated.
They are happy with progress- not worried with recent events such as Advisory committee appointed , Omthera etc.
I didn't ask why share price so low- as I got free coffee and biscuits. !! :)
Edit- Presentation here.
Looking back over notes they mentioned they are 6 months ahead of where they were when Reliant launched Lovaza. I am assuming that is due to greater interest in healthcare and an increase in poor diet and general lack of exercise since 2007.
As Lovaza has run out of Patent they only had Patent for 6 to 7 years? Amarin has patent to 2030 or more. 17 years.
Disclosure: I am long AMRN.
Additional disclosure: My disclosure is based on my opinion only and relevant information taken from conference call and various other sources of information. It has no importance in you making a decision to invest your money in AMRN or not.